PILOT-STUDY OF COMPUTERIZED DIFFERENTIATION OF HUNTINGTONS-DISEASE, SCHIZOPHRENIC, AND PARKINSONS-DISEASE PATIENTS USING THE CONTINGENT NEGATIVE-VARIATION

被引:8
作者
JERVIS, BW
SAATCHI, MR
ALLEN, EM
HUDSON, NR
OKE, S
GRIMSLEY, M
机构
[1] PLYMOUTH GEN HOSP,DEPT CLIN NEUROPHYSIOL,PLYMOUTH PL6 8DH,ENGLAND
[2] SHEFFIELD CITY POLYTECH,SCH COMP & MANAGEMENT SCI,SHEFFIELD S11 8HD,ENGLAND
关键词
CONTINGENT NEGATIVE VARIATION; DISCRIMINANT ANALYSIS; EEG PROCESSING; HUNTINGTONS DISEASE; PARKINSONS DISEASE; PATIENT DIFFERENTIATION; SCHIZOPHRENIA; SPECTRAL ANALYSIS;
D O I
10.1007/BF02446882
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
In this study a potential known as the contingent negative variation was used to differentiate between schizophrenic, Parkinson's disease (PD), Huntington's disease (HD) patients and normal control subjects. The aim was to assist diagnosis and the avoidance of false diagnosis. 20 schizophrenic, 16 PD, 11 HD and 43 normal control subjects were enrolled for this study. The discriminatory variables were generated by applying spectral analysis to pre- and post-stimulus sections of the CNV responses. The patient differentiation was achieved by using the measured variables in a discriminant analysis program. It was possible to accurately differentiate between HD, schizophrenic, PD patients and normal control subjects. It was also attempted to differentiate between HD and schizophrenic patients, HD and PD patients, and schizophrenic and PD patients. The test results indicated that the method is useful in differentiating between these patients. This study had a number of limitations. It was based on a limited number of individuals, and an analysis of medication effects on the test results and the test-retest reliability assessment could not be carried out.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 41 条
[1]   2 MEASURES OF MENTAL-ILLNESS - CONTINGENT NEGATIVE-VARIATION AND SPIRAL AFTEREFFECT [J].
ABRAHAM, P .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1989, 93 (01) :291-293
[2]  
ADAMS JH, 1984, NEUROPATHOLOGY
[3]  
BENNET JP, 1988, COMPREHENSIVE MANAGE, P63
[4]  
CHIAPPA KH, 1990, EVOKED POTENTIALS CL
[5]  
COHEN J, 1974, METHODS PHYSL PSYCHO, P259
[6]   CELL LOSS IN THE HIPPOCAMPUS OF SCHIZOPHRENICS [J].
FALKAI, P ;
BOGERTS, B .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1986, 236 (03) :154-161
[7]  
GIBB WRG, 1987, PARKINSONS DISEASE C, P3
[8]  
Goldman-Rakic PS, 1987, HDB PHYSL 1, P373, DOI DOI 10.1002/CPHY.CP010509
[9]   A POLYMORPHIC DNA MARKER GENETICALLY LINKED TO HUNTINGTONS-DISEASE [J].
GUSELLA, JF ;
WEXLER, NS ;
CONNEALLY, PM ;
NAYLOR, SL ;
ANDERSON, MA ;
TANZI, RE ;
WATKINS, PC ;
OTTINA, K ;
WALLACE, MR ;
SAKAGUCHI, AY ;
YOUNG, AB ;
SHOULSON, I ;
BONILLA, E ;
MARTIN, JB .
NATURE, 1983, 306 (5940) :234-238
[10]   HUNTINGTONS-DISEASE - PREDICTION AND PREVENTION [J].
HARPER, PS ;
QUARRELL, OWJ ;
YOUNGMAN, S .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1988, 319 (1194) :285-298